Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Aug. 9, 2022
Abstract
Background
:
Deprescribing
is
a
planned
and
supervised
process
of
reducing,
substituting,
or
discontinuing
medicines
that
are
unnecessary
deemed
to
be
harmful
tailored
individual
patient
needs.
The
study
aimed
assess
the
knowledge,
attitude,
practice
healthcare
providers
towards
deprescribing
in
Ambo
university
referral
hospital
(AURH)
AGH
(Ambo
general
hospital),
Ethiopia
identify
perceived
barriers
enablers
deprescribing.
Methods:
A
self-administered
structured
questionnaire
was
used
collect
information
from
with
facilities
based
cross-sectional
design
July
September
2021.
data
cleaned,
coded,
entered
into
SPSS
version
25
statistical
software
for
analysis.
Descriptive
statistics
were
describe
finding.
Results
Two
hundreds
twenty
three
(223)
health
care
AURH
took
part
study.
Among
participants,
155(69.5%)
heard
about
but
125(56.1%)
reportedly
had
insufficient
knowledge
More
than
fourth
respondents
(75.8%)
agreed
does
benefits
harms
patients
terms
decreasing
pills
burden,
cost
medication,
drug-drug
interaction,
improving
overall
treatment
outcomes
quality
life.
One
forty-seven
(65.9%)
reported
they
consciously
practiced
Respondents
149
(66.8%)
them
deprescribed
antipsychotic
which
followed
by
antidepressant
142(63.7%)
antihypertensive
112(50.2%)
medications.
noted
engagement
pharmacists
83
(37.2%),
existence
evidence
user-friendly
guidelines
78(34.9%),
having
sufficient
57
(
25.6%)
effective
multidisciplinary
team
collaboration
communication
51
(22.9%)
most
often
practicing
On
other
hand,
lack
organizational
support
85(38.1%),
clear
risk-benefit
regarding
75(33.6%),
time
constraint
access
evidence-based
54(24.2%)
frequently
barriers.
Conclusion
half
three-fourth
patients.
In
general,
identified
interconnected
patient-related,
provider-related,
system-related
Therefore,
multi-level
approach
through
innovations
initiatives
should
sought
address
International Journal of Environmental Research and Public Health,
Journal Year:
2023,
Volume and Issue:
20(6), P. 4957 - 4957
Published: March 11, 2023
Deprescribing
is
a
notable
approach
to
improve
medication
management,
but
few
healthcare
systems
recognize
it.
To
introduce
new
practice,
it
important
examine
the
factors
influencing
provision
of
or
elaborate
cognitive
service
within
desired
setting.
This
study
explores
perceived
barriers
and
facilitators
deprescribing
by
primary
providers,
identifies
associated
with
willingness
suggest
deprescribing.
A
cross-sectional
survey
was
conducted
(in
Croatia,
between
October
2021
January
2022)
using
validated
comprehensive
providers'
opinions,
preferences,
attitudes
towards
(CHOPPED)
questionnaire.
total
419
pharmacists
124
physicians
participated.
Participants
showed
high
deprescribe,
significantly
higher
scores
in
than
(5.00
(interquartile
range-IQR
5-5)
vs.
4.00
(IQR
4-5),
p
<
0.001).
Pharmacists
had
seven
out
ten
(knowledge,
awareness,
collaboration
facilitators,
competencies
system
barriers,
barriers)
while
remaining
three
(patient
patient
there
no
difference
scores.
The
strongest
positive
correlation
found
for
(G
=
0.331,
0.001,
G
0.309,
respectively),
knowledge,
0.446,
0.001;
0.771,
0.259,
0.043,
respectively).
Primary
providers
are
willing
face
different
facilitators.
For
pharmacists,
most
were
extrinsic,
they
more
intrinsic
related.
stated
results
provide
target
areas
which
one
could
focus
upon
help
engage
Pharmacy,
Journal Year:
2022,
Volume and Issue:
10(4), P. 76 - 76
Published: July 1, 2022
Successful
implementation
of
deprescribing
requires
exploring
healthcare
professionals’
opinions,
preferences,
and
attitudes
towards
deprescribing.
The
aim
this
study
was
to
develop
validate
the
questionnaire
providers’
opinions
preferences
(CHOPPED
questionnaire).
This
a
cross-sectional
on-line
survey.
A
comprehensive
58-item
questionnaire,
in
two
versions
(for
pharmacists
physicians),
developed
through
an
extensive
literature
review
interviews
with
experts.
validated,
its
reliability
assessed
data
collected
from
356
109
physicians.
Exploratory
factor
analysis
performed,
37-
35-item
questionnaires
were
developed.
Ten
factors
identified:
knowledge,
awareness,
patient
barriers
facilitators,
competencies
collaboration
system
facilitators.
CHOPPED
tool
has
satisfactory
face,
content
(CVR
>
0.62)
(content
validity
ratio),
construct,
criterion
validity.
statistics
all
both
acceptable
Cronbach’s
alpha
0.6.
Test−retest
showed
that
gamma
rank
correlations
total
scores
strong
very
(between
0.519
0.938).
can
be
used
as
valid
reliable
explore
toward
discontinuing
medications
primary
care
setting
Croatia.
Exploratory Research in Clinical and Social Pharmacy,
Journal Year:
2023,
Volume and Issue:
10, P. 100265 - 100265
Published: April 13, 2023
The
role
of
community
pharmacists
has
evolved
in
recent
years
with
expansion
pharmacy
services
offered.
extent
to
which
patients
utilise
such
pharmacies
Ireland
is
unclear.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: March 17, 2023
Abstract
Introduction
The
role
of
community
pharmacists
has
evolved
in
recent
years
with
expansion
pharmacy
services
offered.
This
study
aims
to
assess
use
among
adults
aged
≥50
Ireland,
and
determine
the
demographic
clinical
factors
associated
use.
Methods
cross-sectional
included
community-dwelling
participants
wave
4
Irish
Longitudinal
Study
on
Ageing
(TILDA),
≥56
who
were
self-respondents.
TILDA
is
a
nationally
representative
cohort
study,
data
collected
during
2016.
collects
participant
demographics
health
data,
addition
information
several
when
visiting
last
12
months.
Characteristics
summarised.
Multivariate
logistic
regression
was
used
examine
association
reporting
(i)
any
service
(ii)
requesting
medicines
advice.
Results
Among
5,782
(55.5%
female,
mean
age
68
years),
96.6%
(5,587)
reported
previous
months,
almost
one
fifth
these
(1,094)
availed
at
least
specified
service.
most
common
non-dispensing
advice
about
medications
(786,
13.6%),
blood
pressure
monitoring
(184,
3.2%),
vaccination
(166,
2.9%).
Controlling
for
other
factors,
female
sex
(odds
ratio
(OR)
1.32,
95%CI
1.14-1.52),
third-level
education
(OR
1.85,
1.51-2.27),
higher
rates
GP
visits,
private
insurance
1.29,
1.07-1.56),
number
medications,
loneliness,
respiratory
condition
diagnosis
1.42,
1.14-1.74)
likelihood
availing
services.
relationship
between
similar.
Conclusion
A
high
proportion
middle-aged
older
visit
avail
Despite
advances
offered
pharmacies,
remains
core
pharmacists’
practice.
Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: May 13, 2022
Abstract
Background
:
Deprescribing
is
a
new
approach
in
which
healthcare
providers
try
to
improve
patient's
prescription
regimen
by
removing
unnecessary
drugs.
The
study
was
aimed
assess
the
knowledge,
attitude,
and
practice
of
primary
health
care
towards
deprescribing
Ambo
university
referral
hospital
(AURH)
AGH
(Ambo
general
hospital)
identify
perceived
barriers
that
prevent
workers
not
practicing
deprescribing.
Method:
A
facility-based
cross
sectional
done
using
structured
questionnaire
on
professionals
from
July
September
2021.
data
cleaned,
coded,
entered
into
SPSS
version
20
statistical
software
for
analysis.
Descriptive
statistics
were
used
describe
dependent
independent
variables.
Result
223
Ambo,
West
Shewa
zone
Oromia,
took
part
study.
Among
participants,
155(69.5%)
heard
about
deprescribing;
around
half
109
(48.9%)
respondents
does
well
than
harm
patients.
147
(65.9%)
reported
they
had
consciously
practiced
deprescribing,
76
(34.1%)
never
yet.
Regarding
barriers,
85(38.1%)
said
lack
organizational
support
followed
clear
risk
benefits
information,
time
access
make
them
practice.
Conclusion
showed
majority
believed
it
important
when
drugs’
potential
harms
out
weight
their
benefits.
participants
involvement
pharmacists
medication
review
makes
Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Aug. 9, 2022
Abstract
Background
:
Deprescribing
is
a
planned
and
supervised
process
of
reducing,
substituting,
or
discontinuing
medicines
that
are
unnecessary
deemed
to
be
harmful
tailored
individual
patient
needs.
The
study
aimed
assess
the
knowledge,
attitude,
practice
healthcare
providers
towards
deprescribing
in
Ambo
university
referral
hospital
(AURH)
AGH
(Ambo
general
hospital),
Ethiopia
identify
perceived
barriers
enablers
deprescribing.
Methods:
A
self-administered
structured
questionnaire
was
used
collect
information
from
with
facilities
based
cross-sectional
design
July
September
2021.
data
cleaned,
coded,
entered
into
SPSS
version
25
statistical
software
for
analysis.
Descriptive
statistics
were
describe
finding.
Results
Two
hundreds
twenty
three
(223)
health
care
AURH
took
part
study.
Among
participants,
155(69.5%)
heard
about
but
125(56.1%)
reportedly
had
insufficient
knowledge
More
than
fourth
respondents
(75.8%)
agreed
does
benefits
harms
patients
terms
decreasing
pills
burden,
cost
medication,
drug-drug
interaction,
improving
overall
treatment
outcomes
quality
life.
One
forty-seven
(65.9%)
reported
they
consciously
practiced
Respondents
149
(66.8%)
them
deprescribed
antipsychotic
which
followed
by
antidepressant
142(63.7%)
antihypertensive
112(50.2%)
medications.
noted
engagement
pharmacists
83
(37.2%),
existence
evidence
user-friendly
guidelines
78(34.9%),
having
sufficient
57
(
25.6%)
effective
multidisciplinary
team
collaboration
communication
51
(22.9%)
most
often
practicing
On
other
hand,
lack
organizational
support
85(38.1%),
clear
risk-benefit
regarding
75(33.6%),
time
constraint
access
evidence-based
54(24.2%)
frequently
barriers.
Conclusion
half
three-fourth
patients.
In
general,
identified
interconnected
patient-related,
provider-related,
system-related
Therefore,
multi-level
approach
through
innovations
initiatives
should
sought
address
